Report Highlights
Radiopharmaceutical Theranostics Market – Scope of Report
TMR’s report on the global radiopharmaceutical theranostics market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global radiopharmaceutical theranostics market for the period 2017–2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global radiopharmaceutical theranostics market from 2023 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the radiopharmaceutical theranostics market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global radiopharmaceutical theranostics market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global radiopharmaceutical theranostics market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global radiopharmaceutical theranostics market.
The report delves into the competitive landscape of the global radiopharmaceutical theranostics market. Key players operating in the global radiopharmaceutical theranostics market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global radiopharmaceutical theranostics market profiled in this report.
Key Questions Answered in Global Radiopharmaceutical Theranostics Market Report
- What is the sales/revenue generated by radiopharmaceutical theranostics across all regions during the forecast period?
- What are the opportunities in the global radiopharmaceutical theranostics market?
- What are the major drivers, restraints, opportunities, and threats in the market?
- Which regional market is set to expand at the fastest CAGR during the forecast period?
- Which segment is expected to generate the highest revenue globally in 2031?
- Which segment is projected to expand at the highest CAGR during the forecast period?
- What are the market positions of different companies operating in the global market?
Report Synopsis
| Report Metrics | Details |
| Base year considered | 2023 |
| Forecast period considered | 2023-2031 |
| Units considered | $ Million |
| Segments covered | By Radioisotope, By Source, By Approach, By Application, By Radiotracer Type, By End-use, By Country |
| Industry covered | Pharmaceutical |
| Countries covered | U.S., Europe, Rest of the World |
| Companies studied |
|
Radiopharmaceutical Theranostics Market – Research Objectives and Research Approach
The comprehensive report on the global radiopharmaceutical theranostics market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global radiopharmaceutical theranostics market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global radiopharmaceutical theranostics market.
- Table 1 : Global Radiopharmaceutical Theranostics Market Value (US$ Mn) Forecast, by Radioisotope, 2017–2031
- Table 2 : Global Radiopharmaceutical Theranostics Market Value (US$ Mn) Forecast, by Application, 2017–2031
- Table 3 : Global Radiopharmaceutical Theranostics Market Value (US$ Mn) Forecast, by Source, 2017–2031
- Table 4 : Global Radiopharmaceutical Theranostics Market Value (US$ Mn) Forecast, by Approach, 2017–2031
- Table 5 : Global Radiopharmaceutical Theranostics Market Value (US$ Mn) Forecast, by Radiotracer Type, 2017–2031
- Table 6 : Global Radiopharmaceutical Theranostics Market Value (US$ Mn) Forecast, by End-user, 2017–2031
- Table 7 : Global Radiopharmaceutical Theranostics Market Value (US$ Mn) Forecast, by Country/Region, 2017–2031
- Table 8 : U.S. Radiopharmaceutical Theranostics Market Value (US$ Mn) Forecast, by Radioisotope, 2017–2031
- Table 9 : U.S. Radiopharmaceutical Theranostics Market Value (US$ Mn) Forecast, by Application, 2017–2031
- Table 10 : U.S. Radiopharmaceutical Theranostics Market Value (US$ Mn) Forecast, by Source, 2017–2031
- Table 11 : U.S. Radiopharmaceutical Theranostics Market Value (US$ Mn) Forecast, by Approach, 2017–2031
- Table 12 : U.S. Radiopharmaceutical Theranostics Market Value (US$ Mn) Forecast, by Radiotracer Type, 2017–2031
- Table 13 : U.S. Radiopharmaceutical Theranostics Market Value (US$ Mn) Forecast, by End-user, 2017–2031
- Table 14 : Europe Radiopharmaceutical Theranostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
- Table 15 : Europe Radiopharmaceutical Theranostics Market Value (US$ Mn) Forecast, by Radioisotope, 2017–2031
- Table 16 : Europe Radiopharmaceutical Theranostics Market Value (US$ Mn) Forecast, by Application, 2017–2031
- Table 17 : Europe Radiopharmaceutical Theranostics Market Value (US$ Mn) Forecast, by Source, 2017–2031
- Table 18 : Europe Radiopharmaceutical Theranostics Market Value (US$ Mn) Forecast, by Approach, 2017–2031
- Table 19 : EU Radiopharmaceutical Theranostics Market Value (US$ Mn) Forecast, by Radiotracer Type, 2017–2031
- Table 20 : EU Radiopharmaceutical Theranostics Market Value (US$ Mn) Forecast, by End-user, 2017–2031
- Table 21 : Rest of the World Radiopharmaceutical Theranostics Market Value (US$ Mn) Forecast, by Radioisotope, 2017–2031
- Table 22 : Rest of the World Radiopharmaceutical Theranostics Market Value (US$ Mn) Forecast, by Application, 2017–2031
- Table 23 : Rest of the World Radiopharmaceutical Theranostics Market Value (US$ Mn) Forecast, by Source, 2017–2031
- Table 24 : Rest of the World Radiopharmaceutical Theranostics Market Value (US$ Mn) Forecast, by Approach, 2017–2031
- Table 25 : Rest of the World Radiopharmaceutical Theranostics Market Value (US$ Mn) Forecast, by Radiotracer Type, 2017–2031
- Table 26 : Rest of the World Radiopharmaceutical Theranostics Market Value (US$ Mn) Forecast, by End-user, 2017–2031
- Figure 1 : Global Radiopharmaceutical Theranostics Market Value (US$ Mn) Forecast, 2017–2031
- Figure 2 : Global Radiopharmaceutical Theranostics Market Value Share, by Radioisotope, 2022
- Figure 3 : Global Radiopharmaceutical Theranostics Market Value Share, by Application, 2022
- Figure 4 : Global Radiopharmaceutical Theranostics Market Value Share, by Source, 2022
- Figure 5 : Global Radiopharmaceutical Theranostics Market Value Share, by Approach, 2022
- Figure 6 : Global Radiopharmaceutical Theranostics Market Value Share, by End-user, 2022
- Figure 7 : Global Radiopharmaceutical Theranostics Market Value Share, by Radiotracer Type, 2022
- Figure 8 : Global Radiopharmaceutical Theranostics Market Value Share Analysis, by Radioisotope, 2022 and 2031
- Figure 9 : Global Radiopharmaceutical Theranostics Market Attractiveness Analysis, Radioisotope, 2023–2031
- Figure 10 : Global Radiopharmaceutical Theranostics Market Revenue (US$ Mn), by Technetium-99, 2017–2031
- Figure 11 : Global Radiopharmaceutical Theranostics Market Revenue (US$ Mn), by Gallium-68, 2017–2031
- Figure 12 : Global Radiopharmaceutical Theranostics Market Revenue (US$ Mn), by Iodine-131, 2017–2031
- Figure 13 : Global Radiopharmaceutical Theranostics Market Revenue (US$ Mn), by Radium-223, 2017–2031
- Figure 14 : Global Radiopharmaceutical Theranostics Market Revenue (US$ Mn), by Fluorine-18, 2017–2031
- Figure 15 : Global Radiopharmaceutical Theranostics Market Revenue (US$ Mn), by Yttrium-90, 2017–2031
- Figure 16 : Global Radiopharmaceutical Theranostics Market Revenue (US$ Mn), by Lutetium-177, 2017–2031
- Figure 17 : Global Radiopharmaceutical Theranostics Market Revenue (US$ Mn), by Copper-67 & 64, 2017–2031
- Figure 18 : Global Radiopharmaceutical Theranostics Market Revenue (US$ Mn), by Samarium-153, 2017–2031
- Figure 19 : Global Radiopharmaceutical Theranostics Market Revenue (US$ Mn), by Others, 2017–2031
- Figure 20 : Global Radiopharmaceutical Theranostics Market Value Share Analysis, by Application, 2022 and 2031
- Figure 21 : Global Radiopharmaceutical Theranostics Market Attractiveness Analysis, Application, 2023–2031
- Figure 22 : Global Radiopharmaceutical Theranostics Market Revenue (US$ Mn), by Oncology, 2017–2031
- Figure 23 : Global Radiopharmaceutical Theranostics Market Revenue (US$ Mn), by Cardiology, 2017–2031
- Figure 24 : Global Radiopharmaceutical Theranostics Market Revenue (US$ Mn), by Others, 2017–2031
- Figure 25 : Global Radiopharmaceutical Theranostics Market Value Share Analysis, by Source, 2022 and 2031
- Figure 26 : Global Radiopharmaceutical Theranostics Market Attractiveness Analysis, Source, 2023–2031
- Figure 27 : Global Radiopharmaceutical Theranostics Market Revenue (US$ Mn), by Nuclear Reactors, 2017–2031
- Figure 28 : Global Radiopharmaceutical Theranostics Market Revenue (US$ Mn), by Cyclotrons, 2017–2031
- Figure 29 : Global Radiopharmaceutical Theranostics Market Value Share Analysis, by Approach, 2022 and 2031
- Figure 30 : Global Radiopharmaceutical Theranostics Market Attractiveness Analysis, Approach, 2023–2031
- Figure 31 : Global Radiopharmaceutical Theranostics Market Revenue (US$ Mn), by Targeted Therapeutic (Rx), 2017–2031
- Figure 32 : Global Radiopharmaceutical Theranostics Market Revenue (US$ Mn), by Companion Diagnostic (DX), 2017–2031
- Figure 33 : Global Radiopharmaceutical Theranostics Market Value Share Analysis, by Radiotracer Type, 2022 and 2031
- Figure 34 : Global Radiopharmaceutical Theranostics Market Attractiveness Analysis, Radiotracer Type, 2023–2031
- Figure 35 : Global Radiopharmaceutical Theranostics Market Revenue (US$ Mn), by Peptidic, 2017–2031
- Figure 36 : Global Radiopharmaceutical Theranostics Market Revenue (US$ Mn), by Non-peptidic, 2017–2031
- Figure 37 : Global Radiopharmaceutical Theranostics Market Value Share Analysis, by End-user 2022 and 2031
- Figure 38 : Global Radiopharmaceutical Theranostics Market Attractiveness Analysis, End-user, 2023–2031
- Figure 39 : Global Radiopharmaceutical Theranostics Market Revenue (US$ Mn), by Hospitals, 2017–2031
- Figure 40 : Global Radiopharmaceutical Theranostics Market Revenue (US$ Mn), by Academic & Research Institutes, 2017–2031
- Figure 41 : Global Radiopharmaceutical Theranostics Market Revenue (US$ Mn), by Others, 2017–2031
- Figure 42 : Global Radiopharmaceutical Theranostics Market Value Share Analysis, by Country/Region, 2022 and 2031
- Figure 43 : Global Radiopharmaceutical Theranostics Market Attractiveness Analysis, by Country/Region, 2023–2031
- Figure 44 : U.S. Radiopharmaceutical Theranostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
- Figure 45 : U.S. Radiopharmaceutical Theranostics Market Value Share Analysis, by Radioisotope, 2022 and 2031
- Figure 46 : U.S. Radiopharmaceutical Theranostics Market Attractiveness Analysis, Radioisotope, 2023–2031
- Figure 47 : U.S. Radiopharmaceutical Theranostics Market Value Share Analysis, by Application, 2022 and 2031
- Figure 48 : U.S. Radiopharmaceutical Theranostics Market Attractiveness Analysis, Application, 2023–2031
- Figure 49 : U.S. Radiopharmaceutical Theranostics Market Value Share Analysis, by Source 2022, and 2031
- Figure 50 : U.S. Radiopharmaceutical Theranostics Market Attractiveness Analysis, Source, 2023–2031
- Figure 51 : U.S. Radiopharmaceutical Theranostics Market Value Share Analysis, by Approach, 2022 and 2031
- Figure 52 : U.S. Radiopharmaceutical Theranostics Market Attractiveness Analysis, Approach, 2023–2031
- Figure 53 : Global Radiopharmaceutical Theranostics Market Value Share Analysis, by Radiotracer Type, 2022 and 2031
- Figure 54 : Global Radiopharmaceutical Theranostics Market Attractiveness Analysis, Radiotracer Type, 2023–2031
- Figure 55 : Global Radiopharmaceutical Theranostics Market Value Share Analysis, by End-user, 2022 and 2031
- Figure 56 : Global Radiopharmaceutical Theranostics Market Attractiveness Analysis, End-user, 2023–2031
- Figure 57 : Europe Radiopharmaceutical Theranostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
- Figure 58 : Europe Radiopharmaceutical Theranostics Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
- Figure 59 : Europe Radiopharmaceutical Theranostics Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
- Figure 60 : Europe Radiopharmaceutical Theranostics Market Value Share Analysis, by Radioisotope, 2022 and 2031
- Figure 61 : Europe Radiopharmaceutical Theranostics Market Attractiveness Analysis, Radioisotope, 2023–2031
- Figure 62 : Europe Radiopharmaceutical Theranostics Market Value Share Analysis, by Application, 2022 and 2031
- Figure 63 : Europe Radiopharmaceutical Theranostics Market Attractiveness Analysis, Application, 2023–2031
- Figure 64 : Europe Radiopharmaceutical Theranostics Market Value Share Analysis, by Source, 2022 and 2031
- Figure 65 : Europe Radiopharmaceutical Theranostics Market Attractiveness Analysis, Source, 2023–2031
- Figure 66 : Europe Radiopharmaceutical Theranostics Market Value Share Analysis, by Approach, 2022 and 2031
- Figure 67 : Europe Radiopharmaceutical Theranostics Market Attractiveness Analysis, Approach, 2023–2031
- Figure 68 : Europe Radiopharmaceutical Theranostics Market Value Share Analysis, by Radiotracer Type, 2022 and 2031
- Figure 69 : Europe Radiopharmaceutical Theranostics Market Attractiveness Analysis, Radiotracer Type, 2023–2031
- Figure 70 : Europe Radiopharmaceutical Theranostics Market Value Share Analysis, by End-user, 2022 and 2031
- Figure 71 : Europe Radiopharmaceutical Theranostics Market Attractiveness Analysis, End-user, 2023–2031
- Figure 72 : Rest of the World Radiopharmaceutical Theranostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
- Figure 73 : Rest of the World Radiopharmaceutical Theranostics Market Value Share Analysis, by Radioisotope, 2022 and 2031
- Figure 74 : Rest of the World Radiopharmaceutical Theranostics Market Attractiveness Analysis, Radioisotope, 2023–2031
- Figure 75 : Rest of the World Radiopharmaceutical Theranostics Market Value Share Analysis, by Application, 2022 and 2031
- Figure 76 : Rest of the World Radiopharmaceutical Theranostics Market Attractiveness Analysis, Application, 2023–2031
- Figure 77 : Rest of the World Radiopharmaceutical Theranostics Market Value Share Analysis, by Source, 2022 and 2031
- Figure 78 : Rest of the World Radiopharmaceutical Theranostics Market Attractiveness Analysis, Source, 2023–2031
- Figure 79 : Rest of the World Radiopharmaceutical Theranostics Market Value Share Analysis, by Approach, 2022 and 2031
- Figure 80 : Rest of the World Radiopharmaceutical Theranostics Market Attractiveness Analysis, Approach, 2023–2031
- Figure 81 : Rest of the World Radiopharmaceutical Theranostics Market Value Share Analysis, by Radiotracer Type, 2022 and 2031
- Figure 82 : Rest of the World Radiopharmaceutical Theranostics Market Attractiveness Analysis, Radiotracer Type, 2023–2031
- Figure 83 : Rest of the World Radiopharmaceutical Theranostics Market Value Share Analysis, by End-user 2022 and 2031
- Figure 84 : Rest of the World Radiopharmaceutical Theranostics Market Attractiveness Analysis, End-user, 2023–2031
Leaders in analytics, research and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a prominent provider of a cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who had a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence.
Similar Reports from Transparency
Radiopharmaceutical Theranostics Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031
Radiopharmaceutical Theranostics Market – Scope of Report
TMR’s report on the global radiopharmaceutical theranostics market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2031. The report provides revenue of the global radiopharmaceutical theranostics market for the period of 2017–2031, ...
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More